Characterisation of Osteoprotegerin Autoantibodies in Coeliac Disease

[1]  J. Bai,et al.  Bone and Celiac Disease , 2016, Current Osteoporosis Reports.

[2]  James F. Wilson,et al.  Autoantibodies to osteoprotegerin are associated with increased bone resorption in rheumatoid arthritis , 2015, Annals of the Rheumatic Diseases.

[3]  J. L. Ding,et al.  Natural Antibodies Bridge Innate and Adaptive Immunity , 2015, The Journal of Immunology.

[4]  Jolanda M. Denham,et al.  Celiac Disease and Autoimmunity: Review and Controversies , 2013, Current Allergy and Asthma Reports.

[5]  Robert G. Nagele,et al.  Natural IgG Autoantibodies Are Abundant and Ubiquitous in Human Sera, and Their Number Is Influenced By Age, Gender, and Disease , 2013, PloS one.

[6]  Xinquan Wang,et al.  Crystal Structure of Human RANKL Complexed with Its Decoy Receptor Osteoprotegerin , 2012, The Journal of Immunology.

[7]  L. Abenavoli,et al.  No evidence of circulating autoantibodies against osteoprotegerin in patients with celiac disease. , 2012, World journal of gastroenterology.

[8]  S. Holland,et al.  Immunodeficiency secondary to anticytokine autoantibodies , 2010, Current opinion in allergy and clinical immunology.

[9]  P. Riches,et al.  Recent insights into the biology of bone turnover. , 2010, The journal of the Royal College of Physicians of Edinburgh.

[10]  S. Ralston,et al.  Osteoporosis associated with neutralizing autoantibodies against osteoprotegerin. , 2009, The New England journal of medicine.

[11]  J. Lacy,et al.  Pseudocirrhosis in a pancreatic cancer patient with liver metastases: a case report of complete resolution of pseudocirrhosis with an early recognition and management. , 2008, World journal of gastroenterology.

[12]  L. Xing,et al.  The RANKL/RANK/OPG pathway , 2007, Current osteoporosis reports.

[13]  M. Milla,et al.  Functional Dissection of Osteoprotegerin and Its Interaction with Receptor Activator of NF-κB Ligand* , 2005, Journal of Biological Chemistry.

[14]  G. Corazza,et al.  Bones in coeliac disease: diagnosis and treatment. , 2005, Best practice & research. Clinical gastroenterology.

[15]  M. Bardella,et al.  Imbalance of Osteoclastogenesis‐Regulating Factors in Patients With Celiac Disease , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[16]  S. Khosla,et al.  Minireview: the OPG/RANKL/RANK system. , 2001, Endocrinology.

[17]  P. Green,et al.  Osteoporosis in a North American adult population with celiac disease , 2001, American Journal of Gastroenterology.

[18]  S. Goldring,et al.  Mechanisms of bone loss in inflammatory arthritis: diagnosis and therapeutic implications , 1999, Arthritis research.

[19]  M. Goto,et al.  Characterization of Structural Domains of Human Osteoclastogenesis Inhibitory Factor* , 1998, The Journal of Biological Chemistry.

[20]  Y. Yazici,et al.  Denosumab in postmenopausal women with low bone mineral density. , 2006, The New England journal of medicine.

[21]  R. Heaney,et al.  Calcium absorption and bone mineral density in celiacs after long term treatment with gluten-free diet and adequate calcium intake , 2004, Osteoporosis International.

[22]  J. Kanis,et al.  Idiopathic hyperphosphatasia and TNFRSF11B mutations: relationships between phenotype and genotype. , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.